Abiopharma

🔍 Cabral Timothy S (Director)

Company: VEEVA SYSTEMS INC (VEEV)

Report Date: 2025-09-01

Detailed Transactions and Holdings:

• Acquired 262 shares of Class A Common Stock (Direct)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 262.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2025-09-01 | Code: H | nature_of_ownership: By the Cabral Family Trust, dated April 17, 2001 | shares_owned_after: 5,500.00 | Footnotes: F2
• Sold 262 shares of Restricted Stock Units (Derivative)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 787.00 | transaction_form_type: 4 | Footnotes: F3, F1, F4, F4

Footnotes:

• F1: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.
• F2: Shares held by the Cabral Family Trust. The Reporting Person is a trustee and beneficiary of the Cabral Family Trust and may be deemed to share voting and dispositive power with regard to the reported shares held by the Cabral Family Trust.
• F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.
• F4: On June 18, 2025, the Reporting Person was granted 1,049 RSUs, under the Issuer's Amended and Restated 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 1, 2025, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.